Elsevier Diagnostic Pathology: Thoracic

This expert volume in the Diagnostic Pathology series is an excellent point-of-care resource for practitioners at all levels of experience and training. Covering every area of thoracic pathology, it incorporates the most recent clinical, pathologic, and molecular knowledge in the field to provide a comprehensive overview of all key issues relevant to today’s practice. Succinctly written, richly illustrated, and easy to use, Diagnostic Pathology: Thoracic, fourth edition, is an essential text for accurate diagnosis and ideal as a day-to-day reference or as a one-stop resource for surgical pathologists, pathology residents, and fellows. Provides a clear framework for a better understanding of the clinical and histopathologic findings of pulmonary, pleural, and mediastinal entities; as well as an intuitive structure that organizes chapters by neoplastic and nonneoplastic lesions and pseudotumoral conditions of the lung Offers major additions to the molecular pathology sections for all relevant entities, specifying the types of genetic mutations found in those tumors, covering next-generation sequencing and other molecular diagnostic techniques, and detailing the ways these genetic alterations can be used by pathologists to distinguish diseases Features new chapters on lung allograft pathology; pulmonary chondroma in Carney syndrome; new soft tissue tumor entities, including clear cell stromal tumor of the lung; and new salivary gland tumors, including hyalinizing clear cell carcinoma Contains timely updates for mesothelioma grading, squamous cell carcinoma grading, and thymic epithelial tumor diagnostics, including new information on thymic carcinoma; new additions to atypical and conventional thymoma; updated content on molecular genetics of thymic tumors; and new molecular genetic and diagnostic biomarker details for several bone and soft tissue chapters, including nomenclature and classification changes for certain soft tissue tumors Features updated criteria and classification of interstitial lung disease based on the 2025 International Multidisciplinary Classification of Interstitial Pneumonias from the American Thoracic Society (ATS) and European Respiratory Society (ERS) Provides important updates that reflect the 2026 World Health Organization (WHO) Classification of Lung Tumors as well as the 2026 molecular testing guidelines from the College of American Pathologists (CAP), Association for Molecular Pathology (AMP), and International Association for the Study of Lung Cancer (IASLC) Features a templated, highly formatted design and concise, bulleted text; diagnostic pearls, a Key Facts summary in every chapter; and an extensive index for easy reference Contains nearly 3,000 high-quality print images (with an additional 900+ images in the complimentary eBook), including gross pathology, radiology, and histology images, and full-color medical illustrations-all carefully annotated to help you quickly recognize established entities Includes a complimentary eBook with everything in the print version as well as additional text, figures, and references, with the ability to search, make notes and highlights, and have content read aloud; additional digital ancillary content may publish up to 6 weeks following the publication date